|
15 Apr 2025 |
Mastek
|
Consensus Share Price Target
|
2196.20 |
3154.83 |
- |
43.65 |
buy
|
|
|
|
|
21 Mar 2025
|
Mastek
|
Sharekhan
|
2196.20
|
3030.00
|
2328.95
(-5.70%)
|
37.97 |
Buy
|
|
|
We participated in a conference call organised by Mastek’s management to address the concerns stemming from the abolishment of NHS England on account of its merger with the Department of Health and Social Care (DHSC).
|
|
27 Feb 2025
|
Mastek
|
Sharekhan
|
2196.20
|
3030.00
|
2371.90
(-7.41%)
|
37.97 |
Buy
|
|
|
Mastek has secured ~$85 million in multiple contracts from a UK public service department to boost Digital, Data and Technology services spread over two years. The company had earlier won a $40 million government services deal during the quarter.
|
|
17 Jan 2025
|
Mastek
|
Sharekhan
|
2196.20
|
3610.00
|
2749.75
(-20.13%)
|
64.37 |
Buy
|
|
|
Mastek reported revenues of $102.9 million, up 0.1% q-o-q/7.6% y-o-y in constant currency (CC), missing our estimates of $104.8 million. Revenue in $ terms was down 0.7%q-o-q/up 9.4% y-o-y while revenue in rupee terms stood at Rs 869.5 crore, up 0.2% q-o-q/10.9% y-o-y.
|
|
18 Oct 2024
|
Mastek
|
Sharekhan
|
2196.20
|
3610.00
|
3017.60
(-27.22%)
|
64.37 |
Buy
|
|
|
Reported revenues stood at $103.6 million, up 4.7% q-o-q/10.2% y-o-y in constant currency (CC) terms, beating our estimates of $101.5 million.
|
|
19 Jul 2024
|
Mastek
|
Sharekhan
|
2196.20
|
3150.00
|
2636.90
(-16.71%)
|
Target met |
Buy
|
|
|
Mastek reported revenues of $97.3 million, up 4.1% q-o-q/9.9% y-o-y in constant currency terms, beating our estimates of $95 million.
|
|
29 Apr 2024
|
Mastek
|
Sharekhan
|
2196.20
|
3150.00
|
2700.35
(-18.67%)
|
Target met |
Buy
|
|
|
Mastek’s reported revenue stood at $93.7 million, down 1.4% q-o-q/up 6% y-o-y in constant currency (CC) terms, which was lower than our estimate of $96.3 million on account of three specific client situations.
|
|
29 Apr 2024
|
Mastek
|
Sharekhan
|
2196.20
|
3150.00
|
2700.35
(-18.67%)
|
Target met |
Buy
|
|
|
Mastek’s reported revenue stood at $93.7 million, down 1.4% q-o-q/up 6% y-o-y in constant currency (CC) terms, which was lower than our estimate of $96.3 million on account of three specific client situations.
|
|
16 Feb 2024
|
Mastek
|
ICICI Direct
|
2196.20
|
3500.00
|
3091.75
(-28.97%)
|
|
Buy
|
|
|
|
|
20 Oct 2023
|
Mastek
|
Sharekhan
|
2196.20
|
2575.00
|
2185.30
(0.50%)
|
Target met |
Buy
|
|
|
|
|
24 Aug 2023
|
Mastek
|
Bonanza
|
2196.20
|
2425.00
|
2200.45
(-0.19%)
|
Target met |
Buy
|
|
|
Post de-merger of Masjeco in FY15, MAST was predominantly UK focused with ~95% revenue from the geography where it was working with government agencies. Over the next 7 years, the company worked on (1) Adding presence in the largest growth market - the US (2) Expanding service areas (3) Professionalizing / institutionalizing the company. Its Revenue/EPS (incl. inorganic) has compounded at 25% / 48% CAGR over the last 7 years.
|
|
19 Jul 2023
|
Mastek
|
Sharekhan
|
2196.20
|
2400.00
|
2170.85
(1.17%)
|
Target met |
Buy
|
|
|
|
|
21 Apr 2023
|
Mastek
|
ICICI Direct
|
2196.20
|
1880.00
|
1773.15
(23.86%)
|
Target met |
Hold
|
|
|
|
|
20 Apr 2023
|
Mastek
|
Sharekhan
|
2196.20
|
1740.00
|
1786.20
(22.95%)
|
Target met |
Hold
|
|
|
|
|
20 Apr 2023
|
Mastek
|
Sharekhan
|
2196.20
|
1740.00
|
1786.20
(22.95%)
|
Target met |
Hold
|
|
|
|
|
17 Mar 2023
|
Mastek
|
Edelweiss
|
2196.20
|
|
1651.85
(32.95%)
|
|
Not Rated
|
|
|
Mastek is a Digital Engineering and Cloud Transformation partner that delivers IT Solutions for ~440 clients in Healthcare and Life Sciences
|
|
23 Oct 2022
|
Mastek
|
ICICI Direct
|
2196.20
|
1800.00
|
1671.80
(31.37%)
|
Target met |
Hold
|
|
|
|
|
23 Jul 2022
|
Mastek
|
ICICI Direct
|
2196.20
|
2000.00
|
2031.45
(8.11%)
|
Target met |
Hold
|
|
|
|
|
22 Apr 2022
|
Mastek
|
ICICI Direct
|
2196.20
|
3100.00
|
2941.70
(-25.34%)
|
|
Hold
|
|
|
|
|
22 Apr 2022
|
Mastek
|
Anand Rathi
|
2196.20
|
3400.00
|
2834.25
(-22.51%)
|
|
Buy
|
|
|
|
|
21 Jan 2022
|
Mastek
|
ICICI Securities Limited
|
2196.20
|
3360.00
|
2846.40
(-22.84%)
|
Target met |
Buy
|
|
|
|